Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-expression of fibrotic genes in inflammatory bowel disease; A localized event? | Front Immunol | 2022 | 36632136 | PubTator, text mining | PubMed |
| An update on the distribution of Blastocystis subtypes in the Americas. | Heliyon | 2022 | 36619449 | PubTator, text mining | PubMed |
| Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36612226 | PubTator, text mining | PubMed |
| Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC). | Cancers (Basel) | 2022 | 36612107 | PubTator, text mining | PubMed |
| Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU). | Front Immunol | 2022 | 36591282 | PubTator, text mining | PubMed |
| Harnessing NK Cells to Control Metastasis. | Vaccines (Basel) | 2022 | 36560427 | PubTator, text mining | PubMed |
| Group B Streptococcus: Virulence Factors and Pathogenic Mechanism. | Microorganisms | 2022 | 36557736 | PubTator, text mining | PubMed |
| The Philosophy of Dermatopathology. | Diagnostics (Basel) | 2022 | 36553098 | PubTator, text mining | PubMed |
| Nectins and Nectin-like Molecules in Colorectal Cancer: Role in Diagnostics, Prognostic Values, and Emerging Treatment Options: A Literature Review. | Diagnostics (Basel) | 2022 | 36553083 | PubTator, text mining | PubMed |
| Regulatory Effects of Curcumin on Platelets: An Update and Future Directions. | Biomedicines | 2022 | 36551934 | PubTator, text mining | PubMed |
| Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells. | PLoS One | 2022 | 36548336 | PubTator, text mining | PubMed |
| Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles. | Hum Genomics | 2022 | 36536459 | PubTator, text mining | PubMed |
| Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals. | Front Immunol | 2022 | 36532041 | PubTator, text mining | PubMed |
| Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology. | Sci Immunol | 2022 | 36525505 | PubTator, text mining | PubMed |
| Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data. | Front Endocrinol (Lausanne) | 2022 | 36523593 | PubTator, text mining | PubMed |
| Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects. | Med Oncol | 2022 | 36520261 | PubTator, text mining | PubMed |
| Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma. | Front Genet | 2022 | 36506303 | PubTator, text mining | PubMed |
| Investigating SH-SY5Y Neuroblastoma Cell Surfaceome as a Model for Neuronal-Targeted Novel Therapeutic Modalities. | Int J Mol Sci | 2022 | 36499391 | PubTator, text mining | PubMed |
| The POLR3G Subunit of Human RNA Polymerase III Regulates Tumorigenesis and Metastasis in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36497214 | PubTator, text mining | PubMed |
| Gene variants in eating disorders. Focus on anorexia nervosa, bulimia nervosa, and binge-eating disorder. | J Prev Med Hyg | 2022 | 36479493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=25